EyePoint Pharmaceuticals Inc (EYPT)
9.18
+0.18
(+2.00%)
USD |
NASDAQ |
Nov 27, 12:22
EyePoint Pharmaceuticals Stock Buybacks (Quarterly): -11.79M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -11.79M |
June 30, 2024 | |
March 31, 2024 | |
December 31, 2023 | -216.20M |
September 30, 2023 | -9.974M |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | -108.48M |
September 30, 2021 | 7.317M |
June 30, 2021 | 0.001M |
March 31, 2021 | -115.67M |
December 31, 2020 | -25.12M |
September 30, 2020 | -4.812M |
June 30, 2020 | 0.295M |
March 31, 2020 | -20.28M |
December 31, 2019 | -1.872M |
September 30, 2019 | -2.412M |
June 30, 2019 | -18.34M |
March 31, 2019 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | -25.20M |
Date | Value |
---|---|
March 31, 2018 | -9.266M |
December 31, 2017 | -6.081M |
September 30, 2017 | -0.963M |
June 30, 2017 | -6.099M |
March 31, 2017 | -2.305M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.01M |
March 31, 2016 | -16.51M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | 0.092M |
March 31, 2014 | -7.005M |
December 31, 2013 | -1.163M |
September 30, 2013 | -9.981M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.066M |
September 30, 2012 | -4.735M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-216.20M
Minimum
Dec 2023
7.317M
Maximum
Sep 2021
-36.18M
Average
-7.393M
Median
Stock Buybacks (Quarterly) Benchmarks
Cassava Sciences Inc | -- |
Regeneron Pharmaceuticals Inc | 600.60M |
Adverum Biotechnologies Inc | 0.00 |
Regenxbio Inc | -0.246M |
Editas Medicine Inc | 0.00 |